Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 28, 2025Discover OncologyOpen Access

Role of non-coding RNAs in radiotherapy sensitivity in non-small cell lung cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

PYPeipei YangRCRui ChenHHHuijuan He

Discussion

Loading...

Member takes

Overview

Analysis shows non-coding RNAs impact radiotherapy efficacy in non-small cell lung cancer, suggesting intervention might improve outcomes.

Key Points

  • Non-coding RNAs enhance radiotherapy sensitivity in non-small cell lung cancer, leading to better treatment outcomes.
  • Research indicates drug resistance decreased by regulating ncRNA expression in lung cancer.
  • Observational analysis on radiotherapy efficacy highlights the role of ncRNAs in resistance mechanisms.
  • Future applications of ncRNAs are crucial for addressing radiotherapy resistance in cancer patients.

Cite This Study

Yang et al. (2025) studied this question.

synapsesocial.com/papers/6928f12ea65b730b9ea7a7edhttps://doi.org/10.1007/s12672-025-03951-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of non-coding RNAs in radiotherapy sensitivity in non-small cell lung cancer2025
  2. 2LncRNAs: key regulators and molecular mechanisms in lung cancer radiosensitivity2026
  3. 3Non‐Coding <scp>RNAs</scp> in Breast Cancer Radioresistance: Mechanisms, Functional Roles and Translational Potentials2025
  4. 4The role of long non-coding RNAs in therapy resistance of cervical cancer and therapeutic potential2026 · 1 citations
  5. 5The Role of LncRNAs in Radio- and Chemoresistance of Glioblastoma: Prognostic or Therapeutic?2025 · 1 citations